Crescent Biopharma GAAP EPS of -$1.27 beats by $0.08

Published 2 days ago Neutral
Crescent Biopharma GAAP EPS of -$1.27 beats by $0.08
Auto
* Crescent Biopharma press release [https://seekingalpha.com/pr/20296481-crescent-biopharma-reports-third-quarter-2025-financial-results-and-recent-business] (CBIO [https://seekingalpha.com/symbol/CBIO]): Q3 GAAP EPS of -$1.27 beats by $0.08.
* Reported a net loss of $24.6M.

MORE ON CRESCENT BIOPHARMA

* Crescent Biopharma: Chasing The Summit Hype [https://seekingalpha.com/article/4814558-crescent-biopharma-stock-chasing-summit-hype]
* Seeking Alpha’s Quant Rating on Crescent Biopharma [https://seekingalpha.com/symbol/CBIO/ratings/quant-ratings]
* Historical earnings data for Crescent Biopharma [https://seekingalpha.com/symbol/CBIO/earnings]
* Financial information for Crescent Biopharma [https://seekingalpha.com/symbol/CBIO/income-statement]